Novel transcript, antisense to transient receptor potential cation channel subfamily C member 3 (LOC102724158)

The novel transcript, antisense to transient receptor potential cation channel subfamily C member 3 (TRPC3), is classified as a natural antisense transcript (NAT), transcribed from the opposite DNA strand relative to the TRPC3 gene. NATs are widespread in eukaryotes and serve important roles as modulators of gene expression. These RNAs can form duplexes with the sense transcript, potentially impacting mRNA processing, stability, and translation, and in particular, can block factors that induce splicing or influence transcript localization. While NATs are increasingly recognized as important for gene regulation, there are no specific functional studies characterizing the biological relevance, disease involvement, or therapeutic utility of this particular antisense transcript[5]. No drugs, biomarkers, or safety issues are associated with it. In summary, this entity is a non-coding regulatory RNA best classified as a natural antisense transcript/lncRNA, but lacks sufficient data to be considered a drug target, biomarker, or disease gene. Structured drug development information is not available for this transcript.

Other names

Novel transcript, antisense to TRPC3ENSG00000289342LOC102724158

None known; no drugs or biomolecules are reported to act directly on this transcript